vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidémia - Činidlá modifikujúce lipidy - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Umoja wa Ulaya -
Kislovakia -
EMA (European Medicines Agency)